Keyphrases
Chronic Obstructive Pulmonary Disease
100%
Lung Surgery
100%
Inhalation Therapy
100%
Disease Groups
50%
Long-acting muscarinic Antagonist
50%
Respiratory Function
25%
After Surgery
18%
Forced Expiratory Volume
18%
Before Surgery
12%
Smokers
12%
Histological Subtypes
12%
Long-acting β2-agonist
12%
ICS-LABA
12%
No Significant Difference
6%
Older Patients
6%
Inhaled Corticosteroids
6%
Inhalation
6%
Long-term Efficacy
6%
Reduction Rate
6%
Preoperative Period
6%
Preoperative Treatment
6%
Pharmacotherapy
6%
Adenocarcinoma
6%
Surgical Candidate
6%
Anatomical Lung Resection
6%
Lung Resection
6%
Short-term Administration
6%
Pulmonary Function Test
6%
Lobectomy
6%
Inhalants
6%
GOLD Stage
6%
Inhaled Agents
6%
Inhaled Drugs
6%
Patient Type
6%
Medicine and Dentistry
Retrospective Study
100%
Chronic Obstructive Pulmonary Disease
100%
Lung Surgery
100%
Inhalational Drug Administration
100%
Muscarinic Antagonist
50%
Respiratory Physiology
25%
Forced Expiratory Volume
18%
Smoking
12%
Pneumonectomy
12%
Drug Therapy
6%
Adenocarcinoma
6%
Preoperative Period
6%
Preoperative Treatment
6%
Lobectomy
6%
Lung Function Test
6%
Exhalation
6%
Pharmacology, Toxicology and Pharmaceutical Science
Retrospective Study
100%
Chronic Obstructive Lung Disease
100%
Muscarinic Receptor Blocking Agent
50%
Pharmacotherapy
6%
Adenocarcinoma
6%